Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-02-07 to 2024-02-08
Current total value of award: $4703.07
Description: 4563579924!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML